ADMA BIOLOGICS, INC.

SEC 4 · Filed

0001140361-26-044291Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Nov 16, 2026

Exercise or conversion by Grossman Adam S

Security
Stock Option (Right to Buy)
Code
M
Shares
15,000
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": "5.40",
  "expiration": "2034-02-26",
  "footnotes": {
    "F1": "Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.",
    "F8": "The option was granted on February 26, 2024 and vests over four years with 25% of the shares of common stock underlying the option (i.e., 217,737 shares) vesting on February 26, 2025, the one-year anniversary of the date of grant, and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 26, 2028."
  },
  "owners": [
    {
      "cik": "0001542517",
      "name": "Grossman Adam S",
      "roles": [
        "director",
        "officer"
      ],
      "title": "President and CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "570950",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "true",
  "security": "Stock Option (Right to Buy)",
  "shares": "15000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "15000"
}
Insider transactionsEvent date Nov 16, 2026

Sale by Grossman Adam S

Security
Common Stock
Code
S
Shares
6,000
Price per share
13.72
Structured facts
{
  "code": "S",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.",
    "F2": "The price reported in Column 4 is the price at which the shares were sold.",
    "F3": "Includes, as of the transaction date, (i) 282,529 unvested restricted stock units (\"RSUs\") granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person\u0027s continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 189,017 unvested RSUs out of 252,022 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person\u0027s continued service as of the applicable vesting date and that will be settled into common stock upon vesting;",
    "F4": "(continued from footnote 3) (iii) 278,864 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person\u0027s continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 143,424 unvested RSUs out of 573,695 RSUs granted on March 6, 2023, vesting quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person\u0027s continued service as of the applicable vesting date and that will be settled into common stock upon vesting;",
    "F5": "(continued from footnote 4) and (v) 1,170,943 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. Each RSU represents a contingent right to receive one share of common stock of the Issuer."
  },
  "owners": [
    {
      "cik": "0001542517",
      "name": "Grossman Adam S",
      "roles": [
        "director",
        "officer"
      ],
      "title": "President and CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "2064777",
  "price": "13.72",
  "row": 3,
  "rule_10b5_1": "true",
  "security": "Common Stock",
  "shares": "6000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Sale by Grossman Adam S

Security
Common Stock
Code
S
Shares
15,000
Price per share
13.72
Structured facts
{
  "code": "S",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.",
    "F2": "The price reported in Column 4 is the price at which the shares were sold."
  },
  "owners": [
    {
      "cik": "0001542517",
      "name": "Grossman Adam S",
      "roles": [
        "director",
        "officer"
      ],
      "title": "President and CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "2070777",
  "price": "13.72",
  "row": 2,
  "rule_10b5_1": "true",
  "security": "Common Stock",
  "shares": "15000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Exercise or conversion by Grossman Adam S

Security
Common Stock
Code
M
Shares
15,000
Price per share
5.40
Structured facts
{
  "code": "M",
  "date": "2026-11-16",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025."
  },
  "owners": [
    {
      "cik": "0001542517",
      "name": "Grossman Adam S",
      "roles": [
        "director",
        "officer"
      ],
      "title": "President and CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "2085777",
  "price": "5.40",
  "row": 1,
  "rule_10b5_1": "true",
  "security": "Common Stock",
  "shares": "15000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}